Clinical Trial Update: A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating how BI 765063 and BI 770371 are taken up in tumors of patients with advanced cancers who are receiving ezabenlimab, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• BI 765063
• BI 770371
• ezabenlimab (ezabenlimab)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING